Screener
Arcutis Biotherapeutics, Inc. ARQT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s enterprise value?
- Arcutis Biotherapeutics, Inc. (ARQT) reported enterprise value of $3.36B in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s enterprise value changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s enterprise value increased by 92.5% year-over-year, from $1.75B to $3.36B.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s enterprise value has grown at a 21.8% compound annual growth rate (CAGR), from $1.35B to $3.63B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Arcutis Biotherapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude